1. Home
  2. TIRX vs HEPA Comparison

TIRX vs HEPA Comparison

Compare TIRX & HEPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIRX
  • HEPA
  • Stock Information
  • Founded
  • TIRX 2010
  • HEPA 2013
  • Country
  • TIRX China
  • HEPA United States
  • Employees
  • TIRX N/A
  • HEPA N/A
  • Industry
  • TIRX Specialty Insurers
  • HEPA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIRX Finance
  • HEPA Health Care
  • Exchange
  • TIRX Nasdaq
  • HEPA Nasdaq
  • Market Cap
  • TIRX 4.6M
  • HEPA 4.7M
  • IPO Year
  • TIRX 2021
  • HEPA N/A
  • Fundamental
  • Price
  • TIRX $1.64
  • HEPA $0.68
  • Analyst Decision
  • TIRX
  • HEPA Hold
  • Analyst Count
  • TIRX 0
  • HEPA 1
  • Target Price
  • TIRX N/A
  • HEPA N/A
  • AVG Volume (30 Days)
  • TIRX 35.9K
  • HEPA 39.0K
  • Earning Date
  • TIRX 08-16-2024
  • HEPA 11-26-2024
  • Dividend Yield
  • TIRX N/A
  • HEPA N/A
  • EPS Growth
  • TIRX N/A
  • HEPA N/A
  • EPS
  • TIRX N/A
  • HEPA N/A
  • Revenue
  • TIRX $697,733.00
  • HEPA N/A
  • Revenue This Year
  • TIRX N/A
  • HEPA N/A
  • Revenue Next Year
  • TIRX N/A
  • HEPA N/A
  • P/E Ratio
  • TIRX N/A
  • HEPA N/A
  • Revenue Growth
  • TIRX N/A
  • HEPA N/A
  • 52 Week Low
  • TIRX $1.53
  • HEPA $0.55
  • 52 Week High
  • TIRX $7.40
  • HEPA $4.47
  • Technical
  • Relative Strength Index (RSI)
  • TIRX 40.39
  • HEPA 52.88
  • Support Level
  • TIRX $1.60
  • HEPA $0.60
  • Resistance Level
  • TIRX $1.85
  • HEPA $0.68
  • Average True Range (ATR)
  • TIRX 0.12
  • HEPA 0.05
  • MACD
  • TIRX -0.03
  • HEPA 0.00
  • Stochastic Oscillator
  • TIRX 7.24
  • HEPA 87.80

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

About HEPA Hepion Pharmaceuticals Inc.

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Share on Social Networks: